• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026

    3/10/26 9:56:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email

    Autonomous, AI-Powered Robot Navigates Directly to Patients' Bedsides - No Staff Escort Required

    LAS VEGAS, NV / ACCESS Newswire / March 10, 2026 / VSee (NASDAQ:VSEE), the leader in telehealth platform innovation, today announced the launch of the VSee AI Robot at HIMSS 2026 - the world's first fully autonomous telehealth AI robot purpose-built for hospital and health system deployment. The VSee AI Robot enables remote clinicians to navigate directly to a patient's bedside without requiring onsite staff assistance, delivering true virtual rounding, rapid telestroke response, and specialist coverage across emergency departments and ICUs at scale.

    The launch marks a pivotal inflection point in care delivery: For the first time, a single autonomous robot can replace or augment multiple manual workflows simultaneously - from remote physician rounding to medication and supplies delivery - while integrating seamlessly into existing clinical AI ecosystems through VSee's proprietary AI Workflow Engine.

    "We built the VSee AI Robot to solve the hardest problem in healthcare staffing: doing more with less, without sacrificing the human connection at the bedside," said Dr. Milton Chen, CEO of VSee. "This isn't a cart with a screen. This is an autonomous clinical teammate that multiplies what every provider on your team can do."

    Autonomous Navigation Meets Clinical-Grade Intelligence

    Unlike traditional telepresence carts that require staff to physically escort or reposition them, the VSee AI Robot uses advanced LiDAR navigation to independently travel hospital corridors, enter patient rooms, and position itself at the bedside - day or night, with 30X optical and infrared night vision. Its surgical-grade display delivers high-definition virtual encounters while programmable drawers enable secure medication and supply delivery on the same autonomous pass.

    Key clinical capabilities include:

    • Remote physician rounding & specialist consults - multisite coverage across ED, ICU, and med-surg

    • Telestroke & rapid response - autonomous dispatch to bedside within minutes

    • Patient check-in & triage - reducing front-line staff burden at intake

    • Medication & supply delivery - programmable, secure, auditable

    • Secure patient identification - HIPAA-compliant, role-based access

    Powered by the VSee AI Workflow Engine: Designed for 100+ Clinical AI Capabilities, Zero IT Rebuild

    The VSee AI Robot is powered by the VSee AI Workflow Engine, a no-code/low-code AI activation layer that enables hospitals to deploy and govern a library of clinical AI modules - from AI Copilot-assisted scheduling and coding to Early Warning vitals deterioration alerts and Stroke CT Hemorrhage notifications - without rebuilding existing IT infrastructure or enduring 12-month integration cycles.

    The platform's modular Building Blocks architecture means health systems can configure and scale in days, not months - with VSee guaranteeing common customizations in as little as 1 day to 1 month.

    Proven at scale, VSee's telehealth platform already powers over 1.5 million video encounters per month, and a capacity of 1,800+ appointments per day, and helped clients like LA County Department of Mental Health onboard 800+ providers in under 7 days.

    Immediate Financial & Operational ROI

    The VSee AI Robot is designed to deliver measurable ROI from day one:

    • Optimize staff utilization - autonomous navigation eliminates the need for escort staff on virtual rounds

    • Reduce staffing costs - one robot enables remote specialists to cover multiple facilities simultaneously

    • Increase revenue - expand specialist service lines (telestroke, tele-ICU) without adding headcount

    See It Live at HIMSS 2026

    The VSee AI Robot will be on live demonstration at HIMSS 2026 in Las Vegas. Attendees can experience autonomous bedside navigation, live virtual rounding workflows, and the VSee AI Workflow Engine dashboard in person at two locations on the show floor:

    • Live Robot Demo - VSee Booth #4468 | Watch the VSee AI Robot navigate and conduct a virtual patient encounter in real time

    • VSee Platform Experience - VSee Booth #4468 | Deep-dive into the AI Workflow Engine, Building Blocks architecture, and integration ecosystem

    Schedule a private meeting or demo at HIMSS: [email protected] | vsee.com

    About VSee Health

    VSee is a leading telehealth platform company trusted by major health systems, federal agencies, and digital health innovators. Built on a no-code/low-code Building Blocks architecture, VSee's unified platform powers virtual care, clinical AI workflows, and now autonomous robotic telehealth delivery. VSee's Integration Ecosystem features rich data connectors and expert in-house integration teams, enabling a superior patient experience and efficient provider workflows - for the lowest lifecycle cost in the industry.

    For more information, visit vsee.com or contact [email protected].

    Forward-Looking Statements

    This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "plans," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-K and other SEC-filed documents. Such filing copies are available on the SEC's website www.sec.gov. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to rely on forward-looking statements.

    Media Contact:
    Anne Chang
    VSee
    [email protected]

    Investor Contact:
    Milton Chen
    VSee Health
    [email protected]

    SOURCE: VSee Health Inc.



    View the original press release on ACCESS Newswire

    Get the next $VSEE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    SEC Filings

    View All

    SEC Form POS EX filed by VSee Health Inc.

    POS EX - VSEE HEALTH, INC. (0001864531) (Filer)

    4/1/26 9:16:42 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form 424B3 filed by VSee Health Inc.

    424B3 - VSEE HEALTH, INC. (0001864531) (Filer)

    4/1/26 9:21:05 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form 10-K filed by VSee Health Inc.

    10-K - VSEE HEALTH, INC. (0001864531) (Filer)

    3/31/26 5:25:02 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite. VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee's AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician's charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity. This new VSee AI solution automatically transcribes visits and generates

    7/14/25 8:17:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke re

    6/23/25 8:27:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

    VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

    5/30/25 4:07:00 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on VSee Lab with a new price target

    Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

    2/24/25 8:42:03 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Leonard Jerry

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    3/24/26 4:36:30 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Aisiku Imoigele

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    3/24/26 4:35:09 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Director O'Sullivan Colin P. was granted 40,107 shares, increasing direct ownership by 58% to 108,731 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    3/6/26 4:31:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 8:45:14 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 5:23:34 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by VSee Health Inc.

    SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    7/5/24 4:29:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Financials

    Live finance-specific insights

    View All

    VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

    12/20/24 9:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

    12/2/24 4:05:00 PM ET
    $SXTP
    $VSEE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services